Patent ID: 9248015
Filing Date: 2016-02-02
CPC Classification: A61F,A61L,B82Y,C12N

Claim Text:
1. A method for producing a preconditioned heart valve, comprising: isolating progenitor cells comprising at least one of endothelial progenitor cells and smooth muscle progenitor cells; differentiating, ex vivo, the progenitor cells into endothelial cells or smooth muscle cells; seeding a matrix having a heart valve shape with the differentiated cells such that the cells attach to the matrix to form at least one cell layer; attaching the seeded matrix to an attachment element in a preconditioning chamber, wherein the attachment element has a channel that is fluidly coupled to a fluid flow system; preconditioning the seeded matrix prior to implantation with the flow system by moving a biological fluid through the seeded matrix, wherein a flow rate and a pulse rate of the biological fluid is controlled so that the seeded matrix is exposed to conditions that mimic flow of blood through a native heart valve, wherein the pulse rate induces a pressure in a range of about 60 mmHg to about 200 mmHg; and continuing exposure of the cells on the surface of the matrix to the flow rate and the pulse rate to allow the seeded cells to develop under fluid flow conditions; wherein the matrix is an electrospun matrix comprising at least one natural component, at least one synthetic polymer component, and a therapeutic agent; wherein the therapeutic agent is coupled to a quantum dot encapsulated in a polymer and the quantum dot is configured to release the coupled therapeutic agent when heated by radiation at a wavelength in the range of about 700 nm to about 1000 nm is applied.